Abbott Laboratories (ABTT34)
Market Closed
10 Aug, 19:55
B3 B3 Primary R$
46. 30
+0.8
+1.7582%
R$
955.17B Market Cap
36.49 P/E Ratio
0.28% Div Yield
32 Volume
4.44 Eps
R$ 45.5
Previous Close Want to track ABTT34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Laboratories (ABTT34) Statistics
Valuation metrics
Market Cap 955.17B
Enterprise value 455.3B
Trailing P/E (ttm) 23.87
Forward P/E -
PEG ratio -1.28
Price/Sales (ttm) 16.58
Price/Book (mrq) 0.95
Enterprise Value/Revenue 1.99
Enterprise Value/EBITDA 7.65
Overview
Shares outstanding 1.74B
Float 1.73B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 948
Average volume (90 days) 1.19K
Price summary
52-Week low 33.5
52-Week high 61.82
Beta 0.65
50-Day moving average 42.15
200-Day moving average 52.55
Dividends and splits
Forward annual dividend rate 0.76
Forward annual dividend yield 0.0204%
Trailing annual dividend rate 0.75
Trailing annual dividend yield 0.0201%
5-Year annual dividend yield 1.54%
Payout ratio 0.47
Dividend Date 21 May 2026
Ex-Dividend Date 13 Apr 2026
Last split factor 3:1
Last split Date 21 Nov 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.14%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.12%
Income Statement
Revenue (ttm) 228.74B
Revenue per share (ttm) 6.48
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 129.24B
EBITDA 11.78B
Net income to common (ttm) 31.69B
Diluted EPS (ttm) 1.5
Quarterly earnings growth (yoy) -0.19%
Balance Sheet
Total cash (mrq) 36.97B
Total cash per share (mrq) 4.19
Total debt (mrq) 173B
Total Debt/Equity (mrq) 64.77
Current ratio (mrq) 1.39%
Book value per share (mrq) 37.82
Cash Flow
Cash flow statement 47.96B
Levered free cash flow (LFCF) 32.14B
